Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage

Neurochemistry International

Volumn 50, Issue 7-8, 2007, Pages 1014-1027

  Yi, Jae Hyuk ^a   Park, Seung Won ^a,d   Kapadia, Ramya ^a,b   Vemuganti, Raghu ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c University of Wisconsin Cardiovascular Research Center   (United States)

^d Chung Ang University   (South Korea)

Author keywords

Cerebral ischemia; Inflammation; PPAR gamma; Transcription factors

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; CELL ADHESION MOLECULE; EARLY GROWTH RESPONSE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P53; STAT3 PROTEIN; TRANSCRIPTION FACTOR;

BRAIN DAMAGE; BRAIN ISCHEMIA; CELLULAR DISTRIBUTION; ENCEPHALITIS; GENE EXPRESSION; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SHORT SURVEY;

ANIMALS; BRAIN; BRAIN DAMAGE, CHRONIC; BRAIN ISCHEMIA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL ADHESION MOLECULES; HUMANS; INFLAMMATION; NF-KAPPA B; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 34250711706     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.04.019     Document Type: Short Survey

References (157)

1. Abbassi O., Kishimoto T.K., McIntire L.V., Anderson D.C., and Smith C.V. E-selectin supports neutrophil rolling in vitro under conditions of flow. J. Clin. Invest. 92 (1993) 2719-2730
2. Barnes P.J., and Adcock I.M. Transcription factors and asthma. Eur. Respir. J. 12 (1998) 221-234 (review)
3. Barone F.C., and Feuerstein G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19 (1999) 819-834
4. Barone F.C., Schmidt D.B., and Hillegass L.M. Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia. Stroke 23 (1992) 1337-1348
5. Bell-Parikh L.C., Ide T., Lawson J.A., McNamara P., Reilly M., and FitzGerald G.A. Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J. Clin. Invest. 112 (2003) 945-955
6. Bergeron M., Yu A.Y., Solway K.E., Semenza G.L., and Sharp F.R. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain. Eur. J. Neurosci. 11 (1999) 4159-4170
7. Bernardo A., Levi G., and Minghetti L. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-delta12,14-prostaglandin J2 in the regulation of microglial functions. Eur. J. Neurosci. 12 (2000) 2215-2223
8. Bevilacqua M.P., Pober J.S., Mendrick D.L., Cotran R.S., and Gimbrone Jr. M.A. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 9238-9242
9. Blanquart C., Barbier O., Fruchart J.C., Staels B., and Glineur C. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J. Steroid Biochem. Mol. Biol. 85 (2003) 267-273
10. Blanco M., Moro M.A., Davalos A., Leira R., Castellanos M., Serena J., Vivancos J., Rodriguez-Yanez M., Lizasoain I., and Castillo J. Increased plasma levels of 15-deoxydelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. Stroke 36 (2005) 1189-1194
11. Bradley M.N., Zhou L., and Smale S.T. C/EBPb regulation in lipopolysaccharide-stimulated macrophages. Mol. Cell Biol. 23 (2003) 4841-4858
12. Braissant O., Foufelle F., Scotto C., Dauca M., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137 (1996) 354-366
13. Braun J.S., Jander S., Schroeter M., Witte O.W., and Stoll G. Spatiotemporal relationship of apoptotic cell death to lymphomonocytic infiltration in photochemically induced focal ischemia of the rat cerebral cortex. Acta Neuropathol. 92 (1996) 255-263
14. Chang T.-H., and Szabo E. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor-γ in non-small cell lung cancer. Cancer Res. 60 (2000) 1129-1138
15. Chen H., Chopp M., Zhang R.L., Bodzin G., Chen Q., Rusche J.R., and Todd III R.F. Anti-CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat. Ann. Neurol. 35 (1994) 458-463
16. Cho S., Park E.M., Kim Y., Liu N., Gal J., Volpe B.T., and Joh T.H. Early c-Fos induction after cerebral ischemia: a possible neuroprotective role. J. Cereb. Blood Flow Metab. 21 (2001) 550-556
17. Chopp M., Zhang R.L., Chen H., Li Y., Jiang N., and Rusche J.R. Postischemic administration of an anti-Mac-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rats. Stroke 25 (1994) 869-875
18. Chu K., Lee S.T., Koo J.S., Jung K.H., Kim E.H., Sinn D.I., Kim J.M., Ko S.Y., Kim S.J., Song E.C., Kim M., and Roh J.K. Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. Brain Res. 1093 (2006) 208-218
19. Cimini A., Benedetti E., Cristiano L., Sebastiani P., D'Amico M.A., D'Angelo B., and Di Loreto S. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons. Neuroscience 130 (2005) 325-337
20. Clark R.K., Lee E.V., White R.F., Jonak Z.L., Feuerstein G.Z., and Barone F.C. Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res. Bull. 35 (1994) 387-392
21. Clark W.M., Lauten J.D., Lessov N., Woodward W., and Coull B.M. The influence of antiadhesion therapies on leukocyte subset accumulation in central nervous system ischemia in rats. J. Mol. Neurosci. 6 (1995) 43-50
22. Clark W.M., Madden K.P., Rothlein R., and Zivin J.A. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule. J. Neurosurg. 75 (1991) 623-627
23. Collino M., Aragno M., Mastrocola R., Gallicchio M., Rosa A.C., Dianzani C., Danni O., Thiemermann C., and Fantozzi R. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur. J. Pharmacol. 530 (2006) 70-80
24. Collino M., Aragno M., Mastrocola R., Benetti E., Gallicchio M., Dianzani C., Danni O., Thiemermann C., and Fantozzi R. Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643. Free Radic. Biol. Med. 41 (2006) 579-589
25. Connolly Jr. E.S., Winfree C.J., Springer T.A., Naka Y., Liao H., Yan S.D., Stern D.M., Solomon R.A., Gutierrez-Ramos J.C., and Pinsky D.J. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97 (1996) 209-216
26. Cristiano L., Cimini A., Moreno S., Ragnelli A.M., Paola, and Ceru M. Peroxisome proliferator-activated receptors (PPARs) and related transcription factors in differentiating astrocyte cultures. Neuroscience 131 (2005) 577-587
27. Cullingford T.E., Bhakoo K., Peuchen S., Dolphin C.T., Patel R., and Clark J.B. Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J. Neurochem. 70 (1998) 1366-1375
28. Danton G.H., and Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J. Neuropathol. Exp. Neurol. 62 (2003) 127-136 (review)
29. Darnell J.E. Validating Stat3 in cancer therapy. Nat. Med. 11 (2005) 595-596
30. Davenpeck K.L., Gauthier T.W., Albertine K.H., and Lefer A.M. Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. Am. J. Physiol. 267 (1994) H622-H630
31. Daynes R.A., and Jones D.C. Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol. 2 (2002) 748-759 (review)
32. Dello Russo C., Gavrilyuk V., Weinberg G., Almeida A., Bolanos J.P., Palmer J., Pelligrino D., Galea E., and Feinstein D.L. Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes. J. Biol. Chem. 278 (2003) 5828-5836
33. del Zoppo G., Ginis I., Hallenbeck J.M., Iadecola C., Wang X., and Feuerstein G.Z. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol. 10 (2000) 95-112 (review)
34. Deplanque D., Gele P., Petrault O., Six I., Furman C., Bouly M., Nion S., Dupuis B., Leys D., Fruchart J.C., Cecchelli R., Staels B., Duriez P., and Bordet R. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J. Neurosci. 23 (2003) 6264-6271
35. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20 (1999) 649-688
36. Devchand P.R., Keller H., Peters J.M., Vazquez M., Gonzalez F.J., and Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384 (1996) 39-43
37. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22 (1999) 391-397 (review)
38. Dragunow M., Beilharz E., Sirimanne E., Lawlor P., Williams C., Bravo R., and Gluckman P. Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to the young rat brain. Brain Res. Mol. Brain Res. 25 (1994) 19-33
39. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., and Springer T.A. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137 (1986) 245-254
40. Eppihimer M.J., Wolitzky B., Anderson D.C., Labow M.A., and Granger D.N. Heterogeneity of expression of E- and P-selectins in vivo. Circ. Res. 79 (1996) 560-569
41. Escher P., and Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat. Res. 448 (2000) 121-138 (review)
42. Feinstein D.L., Spagnolo A., Akar C., Weinberg G., Murphy P., Gavrilyuk V., and Dello Russo C. Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?. Biochem. Pharmacol. 70 (2005) 177-188 (review)
43. Garcia J.H., Liu K.F., Yoshida Y., Lian J., Chen S., and Del Zeppo G.J. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am. J. Pathol. 144 (1994) 188-199
44. Garcia-Criado F.J., Toledo-Pereyra L.H., Lopez-Neblina F., Phillips M.L., Paez-Rollys A., and Misawa K. Role of P-selectin in total hepatic ischemia and reperfusion. J. Am. Coll. Surg. 181 (1995) 327-334
45. Gerszten R.E., Garcia-Zepeda E.A., Lim Y.C., Yoshida M., Ding H.A., Gimbrone Jr. M.A., Luster A.D., Luscinskas F.W., and Rosenzweig A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398 (1999) 718-723
46. Glass C.K., and Ogawa S. Combinatorial roles of nuclear receptors in inflammation and immunity. Nat. Rev. Immunol. 6 (2006) 44-55 (review)
47. Gosset P., Charbonnier A.S., Delerive P., Fontaine J., Staels B., Pestel J., Tonnel A.B., and Trottein F. Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. Eur. J. Immunol. 31 (2001) 2857-2865
48. Hata R., Gass P., Mies G., Wiessner C., and Hossmann K.A. Attenuated c-fos mRNA induction after middle cerebral artery occlusion in CREB knockout mice does not modulate focal ischemic injury. J. Cereb. Blood Flow Metab. 18 (1998) 1325-1335
49. Heo J.H., Lucero J., Abumiya T., Koziol J.A., Copeland B.R., and del Zoppo G.J. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow. Metab. 19 (1999) 624-633
50. Hu B.R., Liu C.L., and Park D.J. Alteration of MAP kinase pathways after transient forebrain ischemia. J. Cereb. Blood Flow Metab. 20 (2000) 1089-1095
51. Huang Z., Huang P.L., Ma J., Meng W., Ayata C., Fishman M.C., and Moskowitz M.A. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-l-arginine. J. Cereb. Blood Flow Metab. 16 (1996) 981-987
52. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20 (1997) 132-139 (review)
53. Iadecola C., and Alexander M. Cerebral ischemia and inflammation. Curr. Opin. Neurol. 14 (2001) 89-94 (review)
54. Iadecola C., Salkowski C.A., Zhang F., Aber T., Nagayama M., Vogel S.N., and Ross M.E. The transcription factor interferon regulatory factor 1 is expressed after cerebral ischemia and contributes to ischemic brain injury. J. Exp. Med. 189 (1999) 719-727
55. Iadecola C., Zhang F., Xu S., Casey R., and Ross M.E. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J. Cereb. Blood Flow Metab. 15 (1995) 378-384
56. Iadecola C., Zhang F., Casey R., Nagayama M., and Ross M.E. Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17 (1997) 9157-9164
57. Iademarco M.F., Barks J.L., and Dean D.C. Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF-alpha in cultured endothelial cells. J. Clin. Invest. 95 (1995) 264-271
58. Iwashita A., Muramatsu Y., Yamazaki T., Muramoto M., Kita Y., Yamazaki S., Mihara K., Moriguchi A., and Matsuoka N. Neuroprotective efficacy of peroxisome proliferator-activated receptor delta (PPAR-{delta}) selective agonists, L-165041 and GW501516, in vitro and in vivo. J. Pharmacol. Exp. Ther. 320 (2007) 1087-1096
59. Jiang C., Ting A.T., and Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391 (1998) 82-86
60. Johansson I.M., Wester P., Hakova M., Gu W., Seckl J.R., and Olsson T. Early and delayed induction of immediate early gene expression in a novel focal cerebral ischemia model in the rat. Eur. J. Neurosci. 12 (2000) 3615-3625
61. Jones D.C., Manning B.M., and Daynes R.A. A role for the peroxisome proliferator-activated receptor alpha in T-cell physiology and ageing immunobiology. Proc. Nutr. Soc. 61 (2002) 363-369 (review)
62. Justicia C., Gabriel C., and Planas A.M. Activation of the JAK/STAT pathway following transient focal cerebral ischemia: signaling through Jak1 and Stat3 in astrocytes. Glia 30 (2000) 253-270
63. Juttler E., Kohrmann M., and Schellinger P.D. Therapy for early reperfusion after stroke. Nat. Clin. Pract. Cardiovasc. Med. 3 (2006) 656-663 (review)
64. Kagansky N., Levy S., and Knobler H. The role of hyperglycemia in acute stroke. Arch. Neurol. 58 (2001) 1209-1212 (review)
65. Kapadia R., Tureyen K., Bowen K.K., Kalluri H., Johnson P.F., and Vemuganti R. Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia. J. Neurochem. 98 (2006) 1718-1731
66. Kitagawa K., Matsumoto M., Mabuchi T., Yagita Y., Ohtsuki T., Hori M., and Yanagihara T. Deficiency of intercellular adhesion molecule 1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia. J. Cereb. Blood Flow Metab. 18 (1998) 1336-1345
67. Kim J.S., Gautam S.C., Chopp M., Zaloga C., Jones M.L., Ward P.A., and Welch K.M. Expression of monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 after focal cerebral ischemia in the rat. J. Neuroimmunol. 56 (1995) 127-134
68. Kindy M.S., Carney J.P., Dempsey R.J., and Carney J.M. Ischemic induction of protooncogene expression in gerbil brain. J. Mol. Neurosci. 2 (1991) 217-228
69. Kliewer S.A., Forman B.M., Blumberg B., Ong E.S., Borgmeyer U., Mangelsdorf D.J., Umesono K., and Evans R.M. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 7355-7359
70. Kochanek P.M., and Hallenbeck J.M. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23 (1992) 1367-1379
71. Kubes P., Jutila M., and Payne D. Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J. Clin. Invest. 95 (1995) 2510-2519
72. Kunz, A., Anrather, J., Zhou, P., Orio, M., Iadecola, C., 2006. Cyclooxygenase-2 does not contribute to postischemic production of reactive oxygen species. J. Cereb. Blood. Flow. Metab. (July 5 Epub).
73. Laudet V., Hanni C., Coll J., Catzeflis F., and Stehelin D. Evolution of the nuclear receptor gene superfamily. EMBO J. 11 (1992) 1003-1013
74. Lee D.W., and Andersen J.K. Role of HIF-1 in iron regulation: potential therapeutic strategy for neurodegenerative disorders. Curr. Mol. Med. 6 (2006) 883-893 (review)
75. Lee J., Kosaras B., Aleyasin H., Han J.A., Park D.S., Ratan R.R., Kowall N.W., Ferrante R.J., Lee S.W., and Ryu H. Role of cyclooxygenase-2 induction by transcription factor Sp1 and Sp3 in neuronal oxidative and DNA damage response. FASEB J. 20 (2006) 2375-2377
76. Lee, J., Reding, M., 2006. Effects of thiazolidinediones on stroke recovery: a case-matched controlled study. Neurochem. Res. (September 8 Epub).
77. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., and Kliewer S.A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272 (1997) 3406-3410
78. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., and Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270 (1995) 12953-12956
79. Li M., Pascual G., and Glass C.K. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol. Cell Biol. 20 (2000) 4699-4707
80. Lin T.N., Cheung W.M., Wu J.S., Chen J.J., Lin H., Chen J.J., Liou J.Y., Shyue S.K., and Wu K.K. 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 481-487
81. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79 (1999) 1431-1568 (review)
82. Liu T., Clark R.K., McDonnell P.C., Young P.R., White R.F., Barone F.C., and Feuerstein G.Z. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25 (1994) 1481-1488
83. Lu A., Tang Y., Ran R., Clark J.F., Aronow B.J., and Sharp F.R. Genomics of the periinfarction cortex after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 23 (2003) 786-810
84. Luo Y., Yin W., Signore A.P., Zhang F., Hong Z., Wang S., Graham S.H., and Chen J. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. J. Neurochem. 97 (2006) 435-448
85. Maeda K., Hata R., Gillardon F., and Hossmann K. Aggravation of brain injury after transient focal ischemia in p53-deficient mice. Mol. Brain Res. 88 (2001) 54-61
86. Maestre-Moreno J.F., Fernandez-Perez M.D., Arnaiz-Urrutia C., Minguez A., Navarrete-Navarro P., and Martinez-Bosch J. Thrombolysis in stroke: inappropriate consideration of the bwindow period Q as the time available. Rev. Neurol. 40 (2005) 274-278
87. Matsuo Y., Onodera H., Shiga Y., Nakamura M., Ninomiya M., Kihara T., and Kogure K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 25 (1994) 1469-1475
88. Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 63 (2004) 901-910
89. Monje M.L., Toda H., and Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302 (2003) 1760-1765
90. Moreno S., Farioli-Vecchioli S., and Ceru M.P. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123 (2004) 131-145
91. Mori E., del Zoppo G.J., Chambers J.D., Copeland B.R., and Arfors K.E. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 23 (1992) 712-718
92. Mukaida N., Morita M., Ishikawa Y., Rice N., Okamoto S., Kasahara T., and Matsushima K. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269 (1994) 13289-13295
93. Nelson P.J., Kim H.T., Manning W.C., Goralski T.J., and Krensky A.M. Genomic organization and transcriptional regulation of the RANTES chemokine gene. J. Immunol. 151 (1993) 2601-2612
94. Nogawa S., Forster C., Zhang F., Nagayama M., Ross M.E., and Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 10966-10971
95. Nurmi A., Lindsberg P.J., Koistinaho M., Zhang W., Juettler E., Karjalainen-Lindsberg M.L., Weih F., Frank N., Schwaninger M., and Koistinaho J. Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke 35 (2004) 987-991
96. Okada Y., Copeland B.R., Mori E., Tung M.M., Thomas W.S., and del Zoppo G.J. P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 25 (1994) 202-211
97. O'Shea J.J., Gadina M., and Schreiber R.D. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell 109 (2002) S121-S131 (review)
98. Ou Z., Zhao X., Labiche L.A., Strong R., Grotta J.C., Herrmann O., and Aronowski J. Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2-mediated protection of brain after experimental cerebral ischemia in rat. Brain Res. 1096 (2006) 196-203
99. Park E.J., Park S.Y., Joe E.H., and Jou I. 15d-PGJ2 and rosiglitazone suppress Janus kinase-STAT inflammatory signaling through induction of suppressor of cytokine signaling 1 (SOCS1) and SOCS3 in glia. J. Biol. Chem. 278 (2003) 14747-14752
100. Pascual G., Fong A.L., Ogawa S., Gamliel A., Li A.C., Perissi V., Rose D.W., Willson T.M., Rosenfeld M.G., and Glass C.K. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437 (2005) 759-763
101. Penberthy T.W., Jiang Y., Luscinskas F.W., and Graves D.T. MCP-1-stimulated monocytes preferentially utilize beta 2-integrins to migrate on laminin and fibronectin. Am. J. Physiol. 269 (1995) C60-C68
102. Pereira M.P., Hurtado O., Cardenas A., Alonso-Escolano D., Bosca L., Vivancos J., Nombela F., Leza J.C., Lorenzo P., Lizasoain I., and Moro M.A. The nonthiazolidinedione PPARgamma agonist L-796,449 is neuroprotective in experimental stroke. J. Neuropathol. Exp. Neurol. 64 (2005) 797-805
103. Pereira M.P., Hurtado O., Cardenas A., Bosca L., Castillo J., Davalos A., Vivancos J., Serena J., Lorenzo P., Lizasoain I., and Moro M.A. Rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. J. Cereb. Blood Flow Metab. 26 (2006) 218-229
104. Planas A.M., Soriano M.A., Berruezo M., Justicia C., Estrada A., Pitarch S., and Ferrer I. Induction of Stat3, a signal transducer and transcription factor, in reactive microglia following transient focal cerebral ischaemia. Eur. J. Neurosci. 8 (1996) 2612-2618
105. Raivich G., and Behrens A. Role of the AP-1 transcription factor c-Jun in developing, adult and injured brain. Prog. Neurobiol. 78 (2006) 347-363 (review)
106. Ricote M., Li A.C., Willson T.M., Kelly C.J., and Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
107. Saluja I., Granneman J.G., and Skoff R.P. PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture. Glia 33 (2001) 191-204
108. Sasaki T., Kitagawa K., Sugiura S., Omura-Matsuoka E., Tanaka S., Yagita Y., Okano H., Matsumoto M., and Hori M. Implication of cyclooxygenase-2 on enhanced proliferation of neural progenitor cells in the adult mouse hippocampus after ischemia. J. Neurosci. Res. 72 (2003) 461-471
109. Satriotomo I., Bowen K.K., and Vemuganti R. JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. J. Neurochem. 98 (2006) 1353-1368
110. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., and Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5 (1999) 554-559
111. Schielke G.P., Yang G.Y., Shivers B.D., and Betz A.L. Reduced ischemic brain injury in interleukin-1 beta converting enzyme-deficient mice. J. Cereb. Blood Flow Metab. 18 (1998) 180-185
112. Setoguchi K., Misaki Y., Terauchi Y., Yamauchi T., Kawahata K., Kadowaki T., and Yamamoto K. Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis. J. Clin. Invest. 108 (2001) 1667-1675
113. Shiga Y., Onodera H., Kogure K., Yamasaki Y., Yashima Y., Syozuhara H., and Sendo F. Neutrophil as a mediator of ischemic edema formation in the brain. Neurosci. Lett. 125 (1991) 110-112
114. Shimazu T., Inoue I., Araki N., Asano Y., Sawada M., Furuya D., Nagoya H., and Greenberg J.H. A peroxisome proliferator-activated receptor-gamma agonist reduces infarct size in transient but not in permanent ischemia. Stroke 36 (2005) 353-359
115. Sharp F.R., and Bernaudin M. HIF1 and oxygen sensing in the brain. Nat. Rev. Neurosci. 5 (2004) 437-448 (review)
116. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell. Biol. 10 (1994) 405-455 (review)
117. Sood V., Colleran K., and Burge M.R. Thiazolidinediones: a comparative review of approved uses. Diabetes Technol. Ther. 2 (2000) 429-440 (review)
118. Soriano S.G., Lipton S.A., Wang Y.F., Xiao M., Springer T.A., Gutierrez-Ramos J.C., and Hickey P.R. Intercellular adhesion molecule-1-deficient mice are less susceptible to cerebral ischemia-reperfusion injury. Ann. Neurol. 39 (1996) 618-624
119. Soriano M.A., Tessier M., Certa U., and Gill R. Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia. J. Cereb. Blood Flow Metab. 20 (2000) 1045-1055
120. Stephenson D., Yin T., Smalstig E.B., Hsu M.A., Panetta J., Little S., and Clemens J. Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20 (2000) 592-603
121. Stoll G., Jander S., and Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56 (1998) 149-171 (review)
122. Storer P.D., Xu J., Chavis J., and Drew P.D. Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. J. Neuroimmunol. 161 (2005) 113-122
123. Straus D.S., Pascual G., Li M., Welch J.S., Ricote M., Hsiang C.H., Sengchanthalangsy L.L., Ghosh G., and Glass C.K. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 4844-4849
124. Sundararajan S., Gamboa J.L., Victor N.A., Wanderi E.W., Lust W.D., and Landreth G.E. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 130 (2005) 685-696
125. Suzuki S., Tanaka K., Nogawa S., Dembo T., Kosakai A., and Fukuuchi Y. Phosphorylation of signal transducer and activator of transcription-3 (Stat3) after focal cerebral ischemia in rats. Exp. Neurol. 170 (2001) 63-71
126. Takagi Y., Harada J., Chiarugi A., and Moskowitz M.A. STAT1 is activated in neurons after ischemia and contributes to ischemic brain injury. J. Cereb. Blood Flow Metab. 22 (2002) 1311-1318
127. Tanaka K., Nogawa S., Ito D., Suzuki S., Dembo T., Kosakai A., and Fukuuchi Y. Activated phosphorylation of cyclic AMP response element binding protein is associated with preservation of striatal neurons after focal cerebral ischemia in the rat. Neuroscience 100 (2000) 345-354
128. Tanaka K., Nogawa S., Nagata E., Ito D., Suzuki S., Dembo T., Kosakai A., and Fukuuchi Y. Persistent CREB phosphorylation with protection of hippocampal CA1 pyramidal neurons following temporary occlusion of the middle cerebral artery in the rat. Exp. Neurol. 161 (2000) 462-471
129. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., and Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J. Neurosci. 21 (2001) 2580-2588
130. Tikka T.M., and Koistinaho J.E. Minocycline provides neuroprotection against n-methyl-D-aspartate neurotoxicity by inhibiting microglia. J. Immunol. 166 (2001) 7233-7527
131. Tureyen K., Kapadia R., Bowen K., Satriotomo I., Liang J., Feinstein D., and Vemuganti R. Peroxisome proliferators-activated receptor-γ agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J. Neurochem. 101 (2007) 41-56
132. Ueda A., Okuda K., Ohno S., Shirai A., Igarashi T., Matsunaga K., Fukushima J., Kawamoto S., Ishigatsubo Y., and Okubo T. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 153 (1994) 2052-2063
133. Van Beek J., Elward K., and Gasque P. Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann. N.Y. Acad. Sci. 992 (2003) 56-71
134. Van de Stolpe A., Caldenhoven E., Stade B.G., Koenderman L., Raaijmakers J.A., Johnson J.P., and van der Saag P.T. 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. J. Biol. Chem. 269 (1994) 6185-6192
135. Vemuganti R., Bowen K.K., Dhodda V.K., Song G., Franklin J.L., Gavva N.R., and Dempsey R.J. Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal ischemia. J. Neurochem. 83 (2002) 1072-1086
136. Vemuganti R., Dempsey R.J., and Bowen K.K. Inhibition of intercellular adhesion molecule-1 protein expression by antisense oligonucleotides is neuroprotective after transient middle cerebral artery occlusion in rat. Stroke 35 (2004) 179-184
137. Vemuganti R., Tureyen K., Brooks N., Bowen K., Liang J., and Svaren J. Transcription factor NGFI-A/EGR1 induction mediates postischemic inflammatory gene expression and brain damage in rodents. Stroke 38 (2007) 556
138. Victor N.A., Wanderi E.W., Gamboa J., Zhao X., Aronowski J., Deininger K., Lust W.D., Landreth G.E., and Sundararajan S. Altered PPARgamma expression and activation after transient focal ischemia in rats. Eur. J. Neurosci. 24 (2006) 1653-1663
139. Vodovotz Y., Kwon N.S., Pospischil M., Manning J., Paik J., and Nathan C. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide. J. Immunol. 152 (1994) 4110-4118
140. Wang X., Yue T.L., Barone F.C., White R.F., Gagnon R.C., and Feuerstein G.Z. Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol. Chem. Neuropathol. 23 (1994) 103-114
141. Wang X., Yue T.L., Barone F.C., and Feuerstein G.Z. Monocyte chemoattractant protein-1 messenger RNA expression in rat ischemic cortex. Stroke 26 (1995) 661-665
142. Welch J.S., Ricote M., Akiyama T.E., Gonzalez F.J., and Glass C.K. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 6712-6717
143. Weyrich A.S., Ma X.Y., Lefer D.J., Albertine K.H., and Lefer A.M. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91 (1993) 2620-2629
144. Williams A.J., Hale S.L., Moffett J.R., Dave J.R., Elliott P.J., Adams J., and Tortella F.C. Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via anti-inflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration. J. Cereb. Blood Flow Metab. 23 (2003) 75-87
145. Willmot M., Gibson C., Gray L., Murphy S., and Bath P. Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic. Biol. Med. 39 (2005) 412-425
146. Woodburn V.L., Hayward N.J., Poat J.A., Woodruff G.N., and Hughes J. The effect of dizocilpine and enadoline on immediate early gene expression in the gerbil global ischaemia model. Neuropharmacology 32 (1993) 1047-1059
147. Woods J.W., Tanen M., Figueroa D.J., Biswas C., Zycband E., Moller D.E., Austin C.P., and Berger J.P. Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons. Brain Res. 975 (2003) 10-21
148. Yan S.F., Lu J., Zou Y.S., Soh-Won J., Cohen D.M., Buttrick P.M., Cooper D.R., Steinberg S.F., Mackman N., Pinsky D.J., and Stern D.M. Hypoxia-associated induction of early growth response-1 gene expression. J. Biol. Chem. 274 (1999) 15030-15040
149. Yan S.F., Fujita T., Lu J., Okada K., Shan Zou Y., Mackman N., Pinsky D.J., and Stern D.M. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat. Med. 6 (2000) 1355-1361
150. Yanaka K., Camarata P.J., Spellman S.R., McCarthy J.B., Furcht L.T., and Low W.C. Antagonism of leukocyte adherence by synthetic fibronectin peptide V in a rat model of transient focal cerebral ischemia. Neurosurgery 40 (1997) 557-563
151. Yrjenheikki J., Keinanen R., Pelikka M., Hokfelt T., and Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15769-15774
152. Yrjenheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., and Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13496-13500
153. Zhang R.L., Chopp M., Jiang N., Tang W.X., Prostak J., Manning A.M., and Anderson D.C. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke 26 (1995) 1438-1442
154. Zhang R.L., Chopp M., Li Y., Zaloga C., Jiang N., Jones M.L., Miyasaka M., and Ward P.A. Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in rat. Neurology 44 (1994) 1747-1751
155. Zhao X., Zhang Y., Strong R., Grotta J.C., and Aronowski J. 15d-prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. J. Cereb. Blood Flow Metab. 26 (2006) 811-820
156. Zhao Y., Patzer A., Gohlke P., Herdegen T., and Culman J. The intracerebral application of the PPARgamma-ligand pioglitazone confers neuroprotection against focal ischaemia in the rat brain. Eur. J. Neurosci. 22 (2005) 278-282
157. Zhao Y., Patzer A., Herdegen T., Gohlke P., and Culman J. Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. FASEB J. 20 (2006) 1162-1175